| Name
|
MTRP-2(180-188)
|
| Other Name
|
|
| Sequence (Single letter abbreviations)
|
SVYDFFVWL
|
| Sequence（Three letter abbreviations）
|
{Ser}{Val}{Tyr}{Asp}{Phe}{Phe}{Val}{Trp}{Leu}
|
| Basic description
|
This peptide is a TRP-tyrosinase-related protein. Its immunization results in effective induction of antitumor immunity. Key Diseases for which peptide SVYDFFVWL is Melanoma, Neoplasms(cancer),Glioma. Drugs related to peptide SVYDFFVWL include mRNA, Liposomes, DNA, Atigens, Epitopes.
|
| The molecular weight
|
1175.340
|
| Chemical formula
|
C61H78M10O14
|
| The purity
|
> 95%
|
| Storage conditions
|
Store at -20°C.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Cancer Immunol Immunother 2005 May;54(5):446-52
Marshall NA., et al. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors. Cancer Res. 2012 Feb;72(3):581-
Banz A., et al. Tumor growth control using red blood cells as the antigen delivery system and poly (I: C). J Immunother. 2012 Jun;35(5):409-17.
|
MTRP-2(180-188)
